--- title: "BPC-157 | PepTracker Pro" description: "A pentadecapeptide derived from human gastric juice, studied for tissue repair and gut-protective properties." lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "Organization", "name": "PepTracker Pro", "url": "https://peptrackerpro.com", "logo": "https://peptrackerpro.com/favicon.png", "description": "Evidence-based educational resource dedicated to improving peptide research literacy.", "contactPoint": { "@type": "ContactPoint", "email": "hello@peptrackerpro.com", "contactType": "customer support" }, "sameAs": [] }, { "@context": "https://schema.org", "@type": "MedicalWebPage", "name": "BPC-157", "description": "A pentadecapeptide derived from human gastric juice, studied for tissue repair and gut-protective properties.", "url": "https://peptrackerpro.com/peptides/bpc-157", "lastReviewed": "2026-05-25", "reviewedBy": { "@type": "Organization", "name": "PepTracker Pro Research Team", "url": "https://peptrackerpro.com" }, "isPartOf": { "@type": "WebSite", "name": "PepTracker Pro", "url": "https://peptrackerpro.com" } }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://peptrackerpro.com" }, { "@type": "ListItem", "position": 2, "name": "Peptides", "item": "https://peptrackerpro.com/peptides" }, { "@type": "ListItem", "position": 3, "name": "BPC-157", "item": "https://peptrackerpro.com/peptides/bpc-157" } ] }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Individuals researching peptides for recovery after physical activity?", "acceptedAnswer": { "@type": "Answer", "text": "BPC-157 is a research peptide studied in preclinical models. A pentadecapeptide derived from human gastric juice, studied for tissue repair and gut-protective properties." } }, { "@type": "Question", "name": "People exploring gut health support options?", "acceptedAnswer": { "@type": "Answer", "text": "BPC-157 is a research peptide studied in preclinical models. A pentadecapeptide derived from human gastric juice, studied for tissue repair and gut-protective properties." } }, { "@type": "Question", "name": "Those interested in emerging tissue-repair research?", "acceptedAnswer": { "@type": "Answer", "text": "BPC-157 is a research peptide studied in preclinical models. A pentadecapeptide derived from human gastric juice, studied for tissue repair and gut-protective properties." } } ] } ] --- [Skip to main content](#main) **Educational information only.** This site does not provide medical advice. [Read full disclaimer](/disclaimer) [PepTracker Pro](/) [Home](/)[Peptides](/peptides)[Compare](/compare)[Glossary](/glossary)[Blog](/blog)[Calculators](/calculators)[Start Here](/start) [Open the App](https://app.peptrackerpro.com) [Peptides](/peptides)/ BPC-157 **Research-only content.** This page is for educational purposes and does not constitute medical advice. [Read full disclaimer →](/research-disclaimer) # BPC-157 Medium Evidence A pentadecapeptide derived from human gastric juice, studied for tissue repair and gut-protective properties. Aliases Body Protection Compound-157 +2 more Evidence Medium Evidence Last Updated 2026-05-25 Reading Time 3 min ## Table of Contents 1. [What It Is](#what-it-is) 2. [Regulatory Status](#regulatory-status) 3. [Why Researchers Study It](#why-researchers-study) 4. [Proposed Mechanisms](#proposed-mechanisms) 5. [Evidence Snapshot](#evidence-snapshot) 6. [Commonly Discussed Benefits](#benefits) 7. [Safety & Cautions](#safety) 8. [Comparisons](#comparisons) 9. [Calculator Tools](#calculator) 10. [Citations](#citations) ## What It Is BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids. It is derived from a protein found in human gastric juice. Preclinical studies have investigated its potential role in tissue healing, including tendons, ligaments, muscles, and the gastrointestinal tract. Research has been conducted primarily in animal models, and human clinical data remains limited. As of 2026, only three small human studies have been published, all from a single Florida research group and lacking placebo controls. New 2026 preclinical studies using quantitative histology have found higher satellite cell counts in BPC-157-treated muscle tissue at post-injury days 7 and 14, with treated myofibers showing larger fiber diameters consistent with faster muscle regeneration. In tendon models, researchers documented accelerated tendon fiber organization, increased collagen type I deposition, and measurable upregulation of VEGF and EGF at injury sites. On April 15, 2026, the FDA announced it will convene an advisory panel in July 2026 to review whether BPC-157 and six other restricted peptides can be legally compounded again. This meeting concerns compounding eligibility only — not FDA drug approval. The FDA has opened docket FDA-2025-N-6895 to collect public comments ahead of the July meeting, with a deadline of July 22, 2026 for comments to be presented to the committee (updated from earlier July 9 deadline). The meeting will address 12 peptides total across two sessions (July 2026 and before February 2027). The FDA formally scheduled the Pharmacy Compounding Advisory Committee (PCAC) meeting for July 23–24, 2026 to review BPC-157-related bulk drug substances (BPC-157 free base and BPC-157 acetate) for potential inclusion on the 503A Bulks List. This meeting will also review KPV, TB-500, and MOTS-c. A favorable PCAC outcome would be a significant step toward formal Category 1 reclassification, though formal rulemaking would still be required before compounding pharmacies can legally prepare these substances. Also known as: Body Protection Compound-157, PL 14736, Bepecin ## Regulatory Status Compounding gray zone — PCAC review pending Removed from Category 2 (significant safety concerns) effective April 22, 2026 after nomination withdrawal. FDA opened public comment docket (FDA-2025-N-6895) for PCAC review on July 23, 2026 to determine 503A bulks list eligibility. Comments due by July 9, 2026 for committee presentation; docket closes July 22, 2026. Compounding pharmacies may resume 503A compounding pending final PCAC recommendation. Effective: April 22, 2026 [View FDA Source](https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026) ## Why Researchers Study It BPC-157 has attracted significant research interest due to its broad tissue-protective effects observed in animal models. Its ability to influence multiple healing pathways — including angiogenesis, nitric oxide synthesis, and growth factor modulation — makes it a compelling subject for preclinical tissue repair studies. ## Proposed Mechanisms - Promotes angiogenesis (new blood vessel formation) at injury sites - Modulates nitric oxide (NO) system to support vascular function - Upregulates growth factor receptors (EGF, VEGF) in damaged tissue - Interacts with the dopaminergic system, potentially influencing gut-brain signaling - Demonstrates cytoprotective effects on gastric mucosa via multiple pathways ## Evidence Snapshot Medium Evidence Low Medium High Study Type Model Outcome Link Animal (rat) Achilles tendon transection Accelerated tendon healing and functional recovery [Source](https://pubmed.ncbi.nlm.nih.gov/29737246/) Animal (rat) NSAID-induced gastric lesions Significant reduction in gastric damage scores [Source](https://pubmed.ncbi.nlm.nih.gov/) In vitro Human fibroblast cultures Increased cell migration and proliferation rates [Source](https://pubmed.ncbi.nlm.nih.gov/) Animal (rat, 2026) Skeletal muscle injury — quantitative histology Higher satellite cell counts at days 7 and 14; larger myofiber diameters indicating faster muscle regeneration; accelerated tendon fiber organization with increased collagen type I and VEGF/EGF upregulation [Source](https://spartanpeptides.com/blog/bpc-157-research-results-2026-preclinical-studies-tissue-repair/) ## Commonly Discussed Benefits [Recovery](/benefits/recovery)[Gut Health](/benefits/gut-health)[Wound Healing](/benefits/wound-healing)[Joint Health](/benefits/joint-health)[Inflammation](/benefits/inflammation)[Pain Relief](/benefits/pain-relief) Researching BPC-157 ? Track it, set reminders, and keep notes in the free app. [Track in App](https://app.peptrackerpro.com/?add=bpc-157) ## Safety & Cautions - Most studies are preclinical (animal models) - Only three small human studies published, all from one research group without placebo controls - Long-term safety profile not established in humans - Not FDA-approved for any medical condition - FDA advisory panel scheduled July 2026 to review compounding eligibility ## Comparisons See how BPC-157 compares to related peptides: [BPC-157 vs GHK-Cu](/compare/bpc-157-vs-ghk-cu) [BPC-157 vs KPV](/compare/bpc-157-vs-kpv) [BPC-157 vs TB-500](/compare/bpc-157-vs-tb-500) ## Calculator Tools Use our research tools to explore dosing and reconstitution data: [Reconstitution Calculator](/calculators) ## Citations 1. \[1\] Sikiric P. et al. — Pentadecapeptide BPC 157 and its role in healing. Curr Pharm Des. 2018 [PubMed](https://pubmed.ncbi.nlm.nih.gov/29737246/) 2. \[2\] Chang CH. et al. — BPC 157 and its healing properties. J Pharmacol Sci. 2020 [PubMed](https://pubmed.ncbi.nlm.nih.gov/) 3. \[3\] BPC-157 Research Results 2026: Preclinical Studies on Tissue Repair — Spartan Peptides [PubMed](https://spartanpeptides.com/blog/bpc-157-research-results-2026-preclinical-studies-tissue-repair/) 4. \[4\] FDA PCAC Notice of Meeting: BPC-157 Bulk Drug Substances — Federal Register. April 16, 2026 [PubMed](https://www.federalregister.gov/documents/2026/04/16/2026-07361/pharmacy-compounding-advisory-committee-notice-of-meeting-establishment-of-a-public-docket-request) 5. \[5\] Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing — PMC 2026 [PubMed](https://pmc.ncbi.nlm.nih.gov/articles/PMC12446177/) 6. \[6\] FDA — July 23-24, 2026 Meeting of the Pharmacy Compounding Advisory Committee [PubMed](https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026) ### Keep researching in the app - Log BPC-157 to your private tracker - Set a dosing reminder - Compare it side-by-side with your stack [Open PepTracker Pro Free](https://app.peptrackerpro.com/?add=bpc-157) [Browse more peptides](/peptides) ## Related Peptides ### GHK-Cu High Evidence A naturally occurring copper-binding peptide studied for skin regeneration, wound healing, and anti-aging effects. [Skin](/benefits/skin)[Anti-Aging](/benefits/anti-aging)[Wound Healing](/benefits/wound-healing)[Hair Growth](/benefits/hair-growth)+2 more [View Details](/peptides/ghk-cu) [\+ Compare](/compare?select=ghk-cu)[](https://app.peptrackerpro.com/?add=ghk-cu) ### KPV Medium Evidence A tripeptide derived from alpha-MSH, studied for anti-inflammatory and gut-protective properties. [Inflammation](/benefits/inflammation)[Gut Health](/benefits/gut-health)[Skin](/benefits/skin)[Immune Support](/benefits/immune-support) [View Details](/peptides/kpv) [\+ Compare](/compare?select=kpv)[](https://app.peptrackerpro.com/?add=kpv) ### TB-500 Medium Evidence A naturally occurring peptide involved in cell migration and tissue repair, studied for wound healing and recovery. [Recovery](/benefits/recovery)[Wound Healing](/benefits/wound-healing)[Inflammation](/benefits/inflammation)[Muscle Growth](/benefits/muscle-growth)+1 more [View Details](/peptides/tb-500) [\+ Compare](/compare?select=tb-500)[](https://app.peptrackerpro.com/?add=tb-500) [PepTracker Pro](/) Educational peptide information and research tracking tools. Not medical advice. #### Explore - [Peptide Directory](/peptides) - [Compare Peptides](/compare) - [Glossary](/glossary) - [Benefits](/benefits/sleep) #### Learn - [Blog](/blog) - [Calculators](/calculators) - [Start Here](/start) - [About](/about) #### Legal - [Editorial Policy](/editorial-policy) - [Research Disclaimer](/research-disclaimer) - [Disclaimer](/disclaimer) - [Privacy Policy](/privacy) - [Terms of Service](/terms) - [Contact](/contact) © 2026 PepTracker Pro. Educational purposes only. Not medical advice. Always consult a licensed healthcare provider.